Prosecution Insights
Last updated: May 29, 2026

Examiner: SOLOLA, TAOFIQ A

Tech Center 1600 • Art Units: 1622 1625

This examiner grants 75% of resolved cases

Performance Statistics

74.8%
Allow Rate
+14.8% vs TC avg
1,473
Total Applications
+16.9%
Interview Lift
752
Avg Prosecution Days
Based on 1464 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
6.4%
§102 Novelty
42.1%
§103 Obviousness
13.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18253094 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 Non-Final OA Vanderbilt University
18029734 HAIR CARE COMPOSITION Final Rejection Conopco, Inc., d/b/a UNILEVER
18262233 PROCESSES RELATED TO FORMATION OF N-(3-CHLORO-1-(PYRIDIN-3-YL)-1H-PYRAZOL-4-YL)-2-(METHYLSULFONYL)PROPANAMIDE Non-Final OA CORTEVA AGRISCIENCE LLC
18259888 COMPOUNDS AND METHODS FOR MODULATING FXR Non-Final OA Terns Pharmaceuticals, Inc.
18328009 EXTRACTION OF CANNABINOIDS FROM WET BIOMASS Non-Final OA CHEMTOR, LP
18327552 TREATMENT OF NEUROLOGICAL DISORDERS Non-Final OA BioCorRx Pharmaceuticals Inc.
18307992 NOVEL COCRYSTALS OF DEXAMETHASONE Non-Final OA Advanced Biomedical Instrumentation Centre Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month